TotalMarketCap

Relmada Therapeutics

RLMDNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$402.679 M

$3.78 -9.47%

Close of 6 Nov 2026

As of 6 Nov 2026, Relmada Therapeutics (RLMD) has a market capitalization of $402.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

$0.00

#2471 by earnings

Shares outstanding

106,669,846

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #202CorMedixCRMD$407.3M
  2. #203Prothena Corp PublicPRTA$406.3M
  3. #204Relmada TherapeuticsRLMD$402.7M
  4. #205MapLight TherapeuticsMPLT$402.2M
  5. #206Assembly BiosciencesASMB$401.7M

What if Relmada Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$264,712.80

Per share 70,123× higher

Bitcoin $1.53T

$14,323.15

Per share 3,794× higher

Apple $5.02T

$47,021.56

Per share 12,456× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Relmada Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.